Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website
Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website
This is a 100% increase over the number of companies cited in the previous year.
The citations in the county include:
- Your HACCP plan does not list a critical limit that ensures control of one or more hazards.
- Procedures for design control have not been established.
- Corrective and preventive action activities and/or results have not been documented.
All of the companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Company Name | Area of Business | Inspection Date | Issue Cited |
|---|---|---|---|
| Airbus Americas, Inc. | Food and Cosmetics | 01/11/2023 | Water filters |
| Clearbrook Foods | Food and Cosmetics | 04/28/2023 | Develop FSVP |
| Computer Programs & Systems, Inc. | Biologics | 09/13/2023 | Design control - no procedures |
| Computer Programs & Systems, Inc. | Biologics | 09/13/2023 | Documentation |
| Computer Programs & Systems, Inc. | Biologics | 09/13/2023 | Statistical techniques - Lack of or inadequate procedures |
| Palmer Foods, LLC | Food and Cosmetics | 06/07/2023 | Critical limits |
Alerts Sign-up